OBIO
Orchestra BioMed Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$6.08
+5.19%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 778.19x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 12.42x
- Price / sales
- 11.43x
- Price / cash flow
- -6.27x
Enterprise value
- Enterprise value
- $336.3M
- EV / sales
- 10.52x
- EV / EBITDA
- -5.89x
- EV / EBIT
- -5.80x
- Market cap
- $365.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026